NANO MED Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Exosome Diagnostics, Therapeutics and Research Tools (BIO149E)

EXO-CD24 (an investigational new drug)

A combination of an immunomodulator (CD24) and a delivery platform (exosomes). Helps normalize immune activity. Nano24 is currently conducting phase 2 clinical trial to evaluate the Safety and Efficacy of EXO-CD24 to prevent clinical deterioration in patients with mild-moderate ARDS.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.